GSK Supply Status
At this time, COVID-19 is not having an impact on GSK supply in the UK.
Please note: this page is updated weekly. If a product is not listed below, GSK are not experiencing supply constraints. Please contact your wholesaler
Product name |
PIP Code |
Status |
Estimated recovery date |
---|---|---|---|
AUGMENTIN SUSP 125/31.25MG/5ML X100ML_UK |
313932 | OUT OF STOCK | LATE SEPTEMBER 2024 |
AVAMYS ANS 0.05% 1X120D_GB | 3438587 | OUT OF STOCK | EARLY SEPTEMBER 2024 |
BECONASE ANS 50MCG 1X200D_GB | 383307 | OUT OF STOCK | EARLY SEPTEMBER 2024 |
BETNOVATE OINTMENT 0.1% 1X30G_UK-GSK | 29488 | OUT OF STOCK | LATE SEPTEMBER 2024 |
BETNOVATE RD CRM 0.025% 100G UK-GSK | 485219 | OUT OF STOCK | LATE SEPTEMBER 2024 |
BETNOVATE RD OINT 0.025% 100G UK-GSK | 485227 | OUT OF STOCK | LATE SEPTEMBER 2024 |
BIOPSY PUNCH 6MM 10 | 8115776 | OUT OF STOCK | LATE NOVEMBER 2024 |
EUMOVATE OINT 0.05% 100G UK-GSK | 29827 | OUT OF STOCK | EARLY SEPTEMBER 2024 |
EUMOVATE OINT 0.05% 30G UK-GSK | 143214 | OUT OF STOCK | EARLY SEPTEMBER 2024 |
IMIGRAN N.S. 20MGX2 CP UK | 2390219 | OUT OF STOCK | EARLY SEPTEMBER 2024 |
IMIGRAN TABLET 100MG 1X6 | 109546 | OUT OF STOCK | LATE NOVEMBER 2024 |
SERETIDE 50/100MCG-ACCUH 1X60D GB | 2602662 | OUT OF STOCK | EARLY SEPTEMBER 2024 |
SEREVENT EVH 25MCG-INH 134A 1X120D GB | 3164142 | OUT OF STOCK | LATE SEPTEMBER 2024 |
ZOVIRAX INJ 250MGX5 CP UK | 101766 | OUT OF STOCK | EARLY OCTOBER 2024 |
Product name |
PIP Code |
Status |
Estimated recovery date |
---|
If you have any queries about the availability of a product, please contact your wholesaler.
3rd Party Distribution
From 1st Sept 2023, GSK and Recordati have agreed a deal whereby RECORDATI PHARMACEUTICALS LIMITED will take over the Distribution and Commercial activities for the following products.
Product name |
PIP Code |
---|---|
AVODART Capsules 0.5mg x 30 | 2921070 |
COMBODART Capsules 0.5mg/0.4mg x 30 | 3542560 |
Orders can be placed at this email address:
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com).
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.